Actylis Executive and Leadership Team

Eugene Amalaha, the Chief Executive Officer at Actylis, directs the overarching corporate strategy and long-term vision for the organization. By overseeing the integration of GMP and non-GMP manufacturing facilities, the Chief Executive Officer ensures that the company meets the complex demands of the Life Sciences and Specialty Chemicals industries. Eugene Amalaha drives the expansion of the global sourcing hub network, providing customers with reliable access to difficult-to-find ingredients. This leadership role involves constant collaboration with the Board to maintain industry-leading standards of quality documentation and regulatory compliance. Through the optimization of the hybrid manufacturing model, the Chief Executive Officer secures the company's position as a premier supplier of critical raw materials. Amalaha fosters a culture of operational excellence, ensuring that every business unit aligns with the core mission of delivering flexible, high-performance ingredient solutions to a diverse international client base.

Douglas Roth, the Chief Financial Officer at Actylis, manages the fiscal health and capital allocation strategies for the entire enterprise. Overseeing global financial reporting and risk management, the Chief Financial Officer ensures that the company maintains the liquidity necessary to support rapid growth in the Agriscience and Specialty Chemicals markets. Douglas Roth directs the financial planning processes that underpin the hybrid manufacturing and sourcing model, balancing cost efficiency with the need for high-quality regulatory compliance. This role involves close coordination with executive leadership to evaluate investment opportunities in new facilities and supply chain infrastructure. By monitoring key performance indicators across all global operations, the Chief Financial Officer provides the data-driven insights required for sustainable expansion. Roth maintains rigorous oversight of financial controls, ensuring that the organization remains a stable and reliable partner for customers requiring specialized raw materials and performance ingredients.

Arpit Butala, the Director and Chief Financial Officer APAC at Actylis, governs the financial operations and strategic growth initiatives across the Asia-Pacific region. Overseeing regional fiscal performance, the Director and Chief Financial Officer APAC ensures that local sourcing hubs and manufacturing activities align with the broader corporate objectives for the Life Sciences sector. Arpit Butala directs the implementation of financial systems that support the unique regulatory requirements of the APAC market, facilitating seamless integration with the global supply chain. This leadership role involves managing regional capital expenditures and optimizing the cost structure of local ingredient procurement. By driving financial transparency and operational efficiency, the Director and Chief Financial Officer APAC strengthens the company's competitive footprint in the region. Butala executes complex financial strategies that allow the organization to respond rapidly to the evolving needs of customers within the diverse and fast-paced Asian industrial landscape.

Trae Etre, the Senior Vice President & Chief Financial Officer at Actylis, architects the financial framework supporting the company's global manufacturing and sourcing operations. Overseeing the treasury functions and corporate accounting, the Senior Vice President & Chief Financial Officer ensures that the organization maintains robust financial health while scaling its portfolio of GMP facilities. Trae Etre directs the financial analysis of supply chain logistics, ensuring that the company delivers cost-effective solutions for customers in the Life Sciences and Agriscience industries. This leadership role involves managing complex financial reporting requirements and ensuring strict adherence to global regulatory standards. By optimizing the capital structure, the Senior Vice President & Chief Financial Officer supports the company's ability to source difficult-to-find ingredients on a global scale. Etre provides the strategic financial guidance necessary to sustain long-term growth and maintain the company's reputation for reliability and quality in the specialty chemicals market.

Damien O'Rourke, the President Global Life Sciences at Actylis, leads the strategic development and commercial execution for the company's life sciences division. Overseeing the delivery of critical raw materials and performance ingredients, the President Global Life Sciences ensures that the organization meets the stringent quality and documentation standards required by pharmaceutical and biotechnology clients. Damien O'Rourke directs the expansion of the global sourcing network, focusing on the acquisition of specialized ingredients that drive innovation in the life sciences sector. This leadership role involves coordinating with manufacturing teams to ensure that custom ingredient requirements are met with precision and speed. By fostering strong relationships with key industry partners, the President Global Life Sciences secures the company's market position as a trusted supplier. O'Rourke executes growth strategies that leverage the company's hybrid manufacturing model to provide flexible, high-value solutions for complex manufacturing challenges worldwide.

Keith Wilkinson, the President (North America) at Actylis, manages the operational and commercial activities across the North American market. Overseeing the regional manufacturing facilities and sourcing hubs, the President (North America) ensures that the company provides reliable and flexible ingredient solutions to local customers in the Life Sciences and Specialty Chemicals industries. Keith Wilkinson directs the implementation of quality standards and regulatory compliance protocols, ensuring that all products meet the rigorous demands of the North American market. This leadership role involves driving regional sales growth and optimizing the supply chain to reduce lead times for critical raw materials. By aligning regional operations with the global corporate mission, the President (North America) strengthens the company's ability to serve diverse manufacturing requirements. Wilkinson executes strategic initiatives that enhance the company's competitive advantage, ensuring that the organization remains a preferred partner for high-performance ingredient sourcing and manufacturing throughout the continent.